Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
G&E Herbal Biotechnology Co (4911 TT)
Watchlist
1
Analysis
Consumer Staples
•
Taiwan
G&E Herbal Biotechnology Company, Limited specializes in the production of western conventional drugs, Chinese traditional drugs, unclassified food, cosmetics, and health products.
more
Watchlist
Filings
Presentations
Events
Earnings/Op Data
Refresh
Exchange Announcement •
08 May 2026 15:43
Announcement Of Board Approval Of Q1 2026 Financial Report
Attachment
Exchange Announcement •
03 May 2026 09:45
Announcement Of The Board Of Directors’ Resolution To Amend The Number Of Directors
Attachment
Exchange Announcement •
03 May 2026 09:41
Announcement That The Board Of Directors Resolved To Change The Number Of Directors To Be Additionally Elected And The List Of Director Candidates.
Attachment
Exchange Announcement •
29 Apr 2026 14:11
Announcement Of The Board Meeting Date For Approval Of The Company'Sfinancial Report For The First Quarter Of 2026
Attachment
Exchange Announcement •
31 Mar 2026 14:36
Announcement: G&E’S New Drug, Sr-T100 Injection Has Received A Consultation Response From Cde, And Will Formally Apply To The Tfda For Phase I Clinical Trial.
Attachment
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.69.1
x